John M Kane Selected Research

Risperidone (Risperdal Consta)

1/2021	Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials.
1/2020	Predicting relapse with residual symptoms in schizophrenia: A secondary analysis of the PROACTIVE trial.
6/2019	Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons.
6/2017	Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
5/2016	Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
11/2015	A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.
11/2015	Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.
11/2015	Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
9/2015	Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
3/2015	Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John M Kane Research Topics

Disease

211	Schizophrenia (Dementia Praecox) 06/2022 - 01/2002
68	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 09/2002
26	Weight Gain 10/2021 - 09/2002
19	Treatment-Resistant Schizophrenia 01/2022 - 01/2002
18	Tardive Dyskinesia 01/2020 - 01/2002
17	Neoplasms (Cancer) 01/2022 - 01/2002
17	Psychomotor Agitation (Akathisia) 01/2020 - 08/2003
16	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 07/2002
11	Mental Disorders (Mental Disorder) 10/2019 - 06/2005
10	Melanoma (Melanoma, Malignant) 01/2022 - 09/2006
9	Mood Disorders (Mood Disorder) 12/2020 - 01/2006
8	Obesity 03/2022 - 01/2003
8	Sarcoma (Soft Tissue Sarcoma) 09/2021 - 07/2004
8	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2003
8	Dyskinesias (Dyskinesia) 01/2020 - 03/2004
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014 - 06/2005
7	Body Weight (Weight, Body) 01/2020 - 09/2002
7	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 04/2008
6	Agranulocytosis (Granulocytopenia) 03/2022 - 04/2011
6	Inflammation (Inflammations) 03/2022 - 04/2006
6	Neuroleptic Malignant Syndrome 10/2021 - 02/2012
5	Myocarditis (Carditis) 03/2022 - 08/2004
5	Hypertension (High Blood Pressure) 01/2022 - 01/2003
5	Drug Hypersensitivity Syndrome 01/2022 - 08/2020
5	Parkinsonian Disorders (Parkinsonism) 06/2019 - 08/2003
5	Mania (Manias) 11/2017 - 09/2003
5	Disease Progression 10/2017 - 09/2006
5	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2002
5	Cognitive Dysfunction 01/2016 - 05/2006
5	Coronary Disease (Coronary Heart Disease) 09/2011 - 04/2006
4	Major Depressive Disorder (Major Depressive Disorders) 05/2022 - 03/2013
4	Drug-Related Side Effects and Adverse Reactions 03/2022 - 01/2020
4	Dementia (Dementias) 01/2022 - 10/2012
4	Sialorrhea 01/2021 - 07/2012
4	Sleepiness 01/2021 - 01/2011
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2020 - 01/2009
4	Hallucinations (Hallucination) 01/2020 - 10/2005
4	Tremor (Tremors) 01/2020 - 04/2008
4	Dyslipidemias (Dyslipidemia) 12/2014 - 11/2008
3	Hyperthermia 01/2022 - 07/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2007
3	Hypersensitivity (Allergy) 09/2021 - 06/2018
3	COVID-19 12/2020 - 01/2020
3	Infections 01/2020 - 11/2002
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2019 - 10/2009
3	Neutropenia 01/2016 - 02/2012
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2015 - 04/2006
3	Headache (Headaches) 05/2015 - 11/2010
3	Prediabetic State (Prediabetes) 12/2014 - 08/2008
3	Insulin Resistance 12/2014 - 01/2007
3	Hyperprolactinemia 08/2014 - 10/2009

Drug/Important Bio-Agent (IBA)

167	Antipsychotic Agents (Antipsychotics)IBA 05/2022 - 01/2002
49	Clozapine (Clozaril)FDA LinkGeneric 03/2022 - 01/2002
39	Olanzapine (Zyprexa)FDA Link 06/2019 - 01/2003
37	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 01/2003
31	Aripiprazole (Abilify)FDA Link 06/2017 - 09/2002
20	Pharmaceutical PreparationsIBA 03/2022 - 10/2005
16	ziprasidone (Geodon)FDA Link 09/2015 - 01/2003
15	Haloperidol (Haldol)FDA LinkGeneric 12/2015 - 05/2002
11	ProlactinIBA 10/2021 - 09/2002
10	Quetiapine Fumarate (Seroquel)FDA Link 06/2019 - 01/2007
8	Cholinergic Antagonists (Anticholinergics)IBA 10/2021 - 08/2003
8	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2003
8	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 05/2012
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2010
6	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2021 - 01/2018
6	Antidepressive Agents (Antidepressants)IBA 09/2021 - 04/2007
6	Polytetrafluoroethylene (Teflon)FDA Link 01/2021 - 01/2016
5	LithiumIBA 01/2022 - 07/2002
5	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 01/2012
5	LipidsIBA 01/2020 - 01/2003
5	valbenazineIBA 01/2019 - 01/2017
4	BenzodiazepinesIBA 10/2021 - 07/2010
4	Paliperidone Palmitate FDA Link 03/2019 - 11/2010
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 04/2009
4	brexpiprazoleIBA 12/2017 - 05/2015
4	Lurasidone Hydrochloride FDA Link 12/2016 - 01/2011
4	Triglycerides (Triacylglycerol)IBA 12/2014 - 01/2007
4	HDL CholesterolIBA 09/2011 - 04/2006
3	Valproic Acid (Depakote)FDA LinkGeneric 03/2022 - 04/2009
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 01/2017
3	lumateperoneIBA 01/2021 - 01/2016
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2020 - 10/2007
3	Biological ProductsIBA 01/2018 - 04/2011
3	Insulin (Novolin)FDA Link 11/2016 - 02/2013
3	Imatinib Mesylate (Gleevec)FDA Link 06/2014 - 01/2009
3	DysbindinIBA 05/2006 - 11/2004
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 06/2022 - 01/2021
2	Dihydrotachysterol (AT 10)IBA 05/2022 - 04/2010

Therapy/Procedure

33	Injections 01/2022 - 01/2003
23	Therapeutics 05/2022 - 07/2002
17	Secondary Prevention 05/2022 - 01/2003
15	Drug Therapy (Chemotherapy) 01/2018 - 01/2002
9	Radiotherapy 09/2021 - 01/2002
6	Patient Readmission 05/2022 - 04/2002
6	Polypharmacy 12/2019 - 01/2007
5	Hyperthermic Intraperitoneal Chemotherapy 01/2022 - 06/2007
3	Lymph Node Excision (Lymph Node Dissection) 04/2019 - 12/2009
3	Neoadjuvant Therapy 01/2018 - 04/2015
3	Time-to-Treatment 05/2016 - 10/2005